especially how third-party testing firms rank the performance of different networks. And I'm following how the major carriers are improving their 5G reach and speeds as well.
The alteration status of rearrangements for each gene-sample pair was exclusive between gene transecting and gene flanking, with the former being prioritized in report. For CDK12, BRCA1, BRCA2, TP53, ...